145 related articles for article (PubMed ID: 26614654)
21. A Novel Methodology for Bioenergetic Analysis of Plasmodium falciparum Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors.
Sakata-Kato T; Wirth DF
ACS Infect Dis; 2016 Dec; 2(12):903-916. PubMed ID: 27718558
[TBL] [Abstract][Full Text] [Related]
22. The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in Plasmodium falciparum.
Dumont L; Richardson MB; van der Peet P; Marapana DS; Triglia T; Dixon MWA; Cowman AF; Williams SJ; Tilley L; McConville MJ; Cobbold SA
mBio; 2019 Dec; 10(6):. PubMed ID: 31822583
[TBL] [Abstract][Full Text] [Related]
23. Determining the Mode of Action of Antimalarial Drugs Using Time-Resolved LC-MS-Based Metabolite Profiling.
Cobbold SA; McConville MJ
Methods Mol Biol; 2019; 1859():225-239. PubMed ID: 30421232
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Approaches Blocking Glycan Synthesis as Targeting Strategy for Malaria.
Gomes PS; Morrot A
Curr Clin Pharmacol; 2017; 12(1):26-30. PubMed ID: 28000556
[TBL] [Abstract][Full Text] [Related]
25. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam.
Thriemer K; Hong NV; Rosanas-Urgell A; Phuc BQ; Ha do M; Pockele E; Guetens P; Van NV; Duong TT; Amambua-Ngwa A; D'Alessandro U; Erhart A
Antimicrob Agents Chemother; 2014 Dec; 58(12):7049-55. PubMed ID: 25224002
[TBL] [Abstract][Full Text] [Related]
26. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast.
Ralph SA; van Dooren GG; Waller RF; Crawford MJ; Fraunholz MJ; Foth BJ; Tonkin CJ; Roos DS; McFadden GI
Nat Rev Microbiol; 2004 Mar; 2(3):203-16. PubMed ID: 15083156
[No Abstract] [Full Text] [Related]
27. Insulin signalling in RBC is responsible for growth stimulation of malaria parasite in diabetes patients.
Balaji SN; Sahasrabuddhe AA; Trivedi V
Biochem Biophys Res Commun; 2020 Jul; 528(3):531-537. PubMed ID: 32505351
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of growth inhibition of intraerythrocytic stages of Plasmodium falciparum by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR).
Bulusu V; Thakur SS; Venkatachala R; Balaram H
Mol Biochem Parasitol; 2011 May; 177(1):1-11. PubMed ID: 21251933
[TBL] [Abstract][Full Text] [Related]
29. Protein trafficking in Plasmodium falciparum-infected red blood cells.
Cooke BM; Lingelbach K; Bannister LH; Tilley L
Trends Parasitol; 2004 Dec; 20(12):581-9. PubMed ID: 15522668
[TBL] [Abstract][Full Text] [Related]
30. Bromophycolide A targets heme crystallization in the human malaria parasite Plasmodium falciparum.
Stout EP; Cervantes S; Prudhomme J; France S; La Clair JJ; Le Roch K; Kubanek J
ChemMedChem; 2011 Sep; 6(9):1572-7. PubMed ID: 21732541
[No Abstract] [Full Text] [Related]
31. Analysis of erythrocyte signalling pathways during Plasmodium falciparum infection identifies targets for host-directed antimalarial intervention.
Adderley JD; John von Freyend S; Jackson SA; Bird MJ; Burns AL; Anar B; Metcalf T; Semblat JP; Billker O; Wilson DW; Doerig C
Nat Commun; 2020 Aug; 11(1):4015. PubMed ID: 32782246
[TBL] [Abstract][Full Text] [Related]
32. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
33. Amodiaquine failure associated with erythrocytic glutathione in Plasmodium falciparum malaria.
Zuluaga L; Pabón A; López C; Ochoa A; Blair S
Malar J; 2007 Apr; 6():47. PubMed ID: 17451604
[TBL] [Abstract][Full Text] [Related]
34. Infectious diseases. Candidate drug breaks down malaria's walls.
Taubes G
Science; 2002 Feb; 295(5558):1207-9. PubMed ID: 11847313
[No Abstract] [Full Text] [Related]
35. Hemolytic and antimalarial effects of tight-binding glyoxalase 1 inhibitors on the host-parasite unit of erythrocytes infected with Plasmodium falciparum.
Wezena CA; Urscher M; Vince R; More SS; Deponte M
Redox Biol; 2016 Aug; 8():348-53. PubMed ID: 26972115
[TBL] [Abstract][Full Text] [Related]
36. 20S proteasomes secreted by the malaria parasite promote its growth.
Dekel E; Yaffe D; Rosenhek-Goldian I; Ben-Nissan G; Ofir-Birin Y; Morandi MI; Ziv T; Sisquella X; Pimentel MA; Nebl T; Kapp E; Ohana Daniel Y; Karam PA; Alfandari D; Rotkopf R; Malihi S; Temin TB; Mullick D; Revach OY; Rudik A; Gov NS; Azuri I; Porat Z; Bergamaschi G; Sorkin R; Wuite GJL; Avinoam O; Carvalho TG; Cohen SR; Sharon M; Regev-Rudzki N
Nat Commun; 2021 Feb; 12(1):1172. PubMed ID: 33608523
[TBL] [Abstract][Full Text] [Related]
37. In Silico Knockout Screening of
Oyelade J; Isewon I; Uwoghiren E; Aromolaran O; Oladipupo O
Biomed Res Int; 2018; 2018():8985718. PubMed ID: 29789805
[TBL] [Abstract][Full Text] [Related]
38. The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic Screens.
Hapuarachchi SV; Cobbold SA; Shafik SH; Dennis AS; McConville MJ; Martin RE; Kirk K; Lehane AM
PLoS Pathog; 2017 Feb; 13(2):e1006180. PubMed ID: 28178359
[TBL] [Abstract][Full Text] [Related]
39. Gibberellin biosynthetic inhibitors make human malaria parasite Plasmodium falciparum cells swell and rupture to death.
Toyama T; Tahara M; Nagamune K; Arimitsu K; Hamashima Y; Palacpac NM; Kawaide H; Horii T; Tanabe K
PLoS One; 2012; 7(3):e32246. PubMed ID: 22412858
[TBL] [Abstract][Full Text] [Related]
40. Metabolic host responses to malarial infection during the intraerythrocytic developmental cycle.
Wallqvist A; Fang X; Tewari SG; Ye P; Reifman J
BMC Syst Biol; 2016 Aug; 10(1):58. PubMed ID: 27502771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
